Adenylosuccinic Acid: An Orphan Drug with Untapped Potential

Adenylosuccinic acid (ASA) is an orphan drug that was once investigated for clinical application in Duchenne muscular dystrophy (DMD). Endogenous ASA participates in purine recycling and energy homeostasis but might also be crucial for averting inflammation and other forms of cellular stress during...

Descripción completa

Detalles Bibliográficos
Autores principales: Rybalka, Emma, Kourakis, Stephanie, Bonsett, Charles A., Moghadaszadeh, Behzad, Beggs, Alan H., Timpani, Cara A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304260/
https://www.ncbi.nlm.nih.gov/pubmed/37375769
http://dx.doi.org/10.3390/ph16060822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304260/
https://www.ncbi.nlm.nih.gov/pubmed/37375769
http://dx.doi.org/10.3390/ph16060822

Ejemplares similares